Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management.
暂无分享,去创建一个
[1] K. Sladek,et al. Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland , 2003, Allergy.
[2] M. Sanak,et al. Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma. , 2003, The Journal of allergy and clinical immunology.
[3] A. Szczeklik,et al. A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. , 2003, The Journal of allergy and clinical immunology.
[4] L. Mastalerz,et al. Non-steroidal anti-inflammatory drugs (NSAID) sensitivity in chronic idiopathic urticaria (CIU): Selective involvement of cyclooxygenase 1 (COX-1) and overproduction of cysteinyl-leukotrienes (cys-LTs)* , 2003 .
[5] R. Simon,et al. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. , 2003, The Journal of allergy and clinical immunology.
[6] M. Sanak,et al. Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist , 2002, European journal of clinical investigation.
[7] G. Scadding,et al. Effects of non‐steroidal anti‐inflammatory drugs on cyclo‐oxygenase and lipoxygenase activity in whole blood from aspirin‐sensitive asthmatics vs healthy donors , 2002, British journal of pharmacology.
[8] R. Flower,et al. Medicine: Lipid signals in pain control , 2002, Nature.
[9] K. Austen,et al. Leukotriene receptors and aspirin sensitivity. , 2002, The New England journal of medicine.
[10] G. Scadding,et al. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. , 2002, The New England journal of medicine.
[11] R. Simon,et al. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[12] S. Shuaib Nasser,et al. Products of 15‐lipoxygenase: are they important in asthma? , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[13] Yusuke Suzuki,et al. Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT(1) antagonist, pranlukast, in Japanese patients with moderate asthma. , 2002, Pharmacogenetics.
[14] N. V. Chandrasekharan,et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[15] L. Mastalerz,et al. Protection against exercise‐induced bronchoconstriction by montelukast in aspirin‐sensitive and aspirin‐tolerant patients with asthma , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[16] Eugene Y. Kim,et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4 , 2002, Nature Medicine.
[17] P. Montuschi,et al. Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. , 2002, American journal of respiratory and critical care medicine.
[18] A. Szczeklik,et al. Testing for aspirin hypersensitivity , 2002, Allergy.
[19] J. Domínguez-Ortega,et al. Nasal provocation test (NPT) with aspirin: a sensitive and safe method to diagnose aspirin‐induced asthma (AIA) , 2002, Allergy.
[20] P. Thompson,et al. The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients , 2002, Thorax.
[21] Masashi Kobayashi,et al. Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma. , 2002, The Journal of allergy and clinical immunology.
[22] J. Mullol,et al. Cyclooxygenase 1 and cyclooxygenase 2 expression is abnormally regulated in human nasal polyps. , 2002, The Journal of allergy and clinical immunology.
[23] L. Mastalerz,et al. Myocardial ischemia possibly mediated by cysteinyl leukotrienes. , 2002, The Journal of allergy and clinical immunology.
[24] M. Sanak,et al. The role of COX‐1 and COX‐2 in asthma pathogenesis and its significance in the use of selective inhibitors , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[25] T. Shenk,et al. Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Zamorano,et al. Aspirin and Salicylates Inhibit the IL-4- and IL-13-Induced Activation of STAT61 , 2002, The Journal of Immunology.
[27] R. Pauwels,et al. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. , 2002, American journal of respiratory and critical care medicine.
[28] T. Shimoda,et al. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. , 2002, Chest.
[29] M. Taniguchi,et al. Possible involvement of mast‐cell activation in aspirin provocation of aspirin‐induced asthma , 2001, Allergy.
[30] M. Sanak,et al. Montelukast for persistent asthma , 2001, The Lancet.
[31] B. Dahlén,et al. Oral and inhalation provocation tests for the diagnosis of aspirin‐induced asthma , 2001, Allergy.
[32] G. Scadding,et al. An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[33] D. Stevenson,et al. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[34] R. Simon,et al. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. , 2001, The Journal of allergy and clinical immunology.
[35] M. Sanak,et al. Leukotriene C4 synthase polymorphism and aspirin-induced asthma. , 2001, The Journal of allergy and clinical immunology.
[36] G. Bochenek,et al. Safety of a specific COX‐2 inhibitor in aspirin‐induced asthma , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[37] J. Murray,et al. Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group. , 2001, The New England journal of medicine.
[38] M. Yacoub,et al. Effects of Prostaglandin E2 and cAMP Elevating Drugs on GM-CSF Release by Cultured Human Airway Smooth Muscle Cells , 2001 .
[39] T. Shoji,et al. Selective cyclo-oxygenase 2 inhibitor in patients with aspirin-induced asthma. , 2000, The Journal of allergy and clinical immunology.
[40] R. Simon,et al. Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[41] M. Sanak,et al. A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leucocytes precludes its value for aspirin sensitivity testing in asthma , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[42] J. Bousquet,et al. Lipoxins and other arachidonate derived mediators in bronchial asthma , 2000, Thorax.
[43] I. Sayers,et al. Variant LTC4 synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast , 2000, Thorax.
[44] W. Hosemann,et al. Surgical treatment of nasal polyposis in patients with aspirin intolerance , 2000, Thorax.
[45] A. Szczeklik,et al. Natural history of aspirin‐induced asthma , 2000 .
[46] M. Sanak,et al. Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. , 2000, American journal of respiratory cell and molecular biology.
[47] Y. Masuho,et al. The Molecular Characterization and Tissue Distribution of the Human Cysteinyl Leukotriene CysLT2 Receptor , 2000 .
[48] T. Bigby,et al. Sp1 and Sp3 function as key regulators of leukotriene C(4) synthase gene expression in the monocyte-like cell line, THP-1. , 2000, American journal of respiratory cell and molecular biology.
[49] J. Murray,et al. Prostaglandin E(2) decreases allergen-stimulated release of prostaglandin D(2) in airways of subjects with asthma. , 2000, American journal of respiratory and critical care medicine.
[50] M. Sanak,et al. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. , 2000, The European respiratory journal.
[51] J. Drazen,et al. 5' flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States. , 2000, The Journal of allergy and clinical immunology.
[52] A. Szczeklik,et al. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. , 2000, The European respiratory journal.
[53] K. Austen,et al. Cell-specific Transcription of Leukotriene C4Synthase Involves a Kruppel-like Transcription Factor and Sp1* , 2000, The Journal of Biological Chemistry.
[54] M. Kowalski,et al. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. , 2000, American journal of respiratory and critical care medicine.
[55] Sakamoto,et al. Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin‐intolerant asthma , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[56] May,et al. Means of increasing sensitivity of an in vitro diagnostic test for aspirin intolerance , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[57] M. Szmidt,et al. A six week double blind, placebo controlled, crossover study of the effect of misoprostol in the treatment of aspirin sensitive asthma. , 1999, Thorax.
[58] D. Stevenson,et al. Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses. , 1999, The Journal of allergy and clinical immunology.
[59] J. Kaprio,et al. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. , 1999, International journal of epidemiology.
[60] J. Mullol,et al. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. , 1999, American journal of respiratory and critical care medicine.
[61] D. Stevenson,et al. Aspirin-induced asthma: advances in pathogenesis and management. , 1999, The Journal of allergy and clinical immunology.
[62] Sakamoto,et al. Anti‐inflammatory effect of roxithromycin in patients with aspirin‐intolerant asthma , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[63] Jilly F. Evans,et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor , 1999, Nature.
[64] Y. Bariş,et al. Occurrence of allergic conditions in asthmatics with analgesic intolerance , 1999, Allergy.
[65] E. Enrique,et al. Failure of montelukast to prevent anaphylaxis to diclofenac , 1999, Allergy.
[66] A. Burks,et al. Prevalence of peanut and tree nut allergy in the US determined by a random digit dial telephone survey. , 1999, The Journal of allergy and clinical immunology.
[67] U. Göde,et al. Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics. , 1999, The European respiratory journal.
[68] Sampson,et al. Biosynthesis of cysteinyl‐leucotrienes in aspirin‐intolerant asthma , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[69] Y. Yamawaki,et al. Effect of acyclovir on bronchoconstriction and urinary leukotriene E4 excretion in aspirin-induced asthma. , 1998, The Journal of allergy and clinical immunology.
[70] E. Pastorello,et al. Atopy and intolerance of antimicrobial drugs increase the risk of reactions to acetaminophen and nimesulide in patients allergic to nonsteroidal anti‐inflammatory drugs , 1998, Allergy.
[71] L. Mastalerz,et al. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. , 1998, The Journal of allergy and clinical immunology.
[72] L. Dubé,et al. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. , 1998, American journal of respiratory and critical care medicine.
[73] J. Vane,et al. Eicosanoids, Aspirin, and Asthma , 1998 .
[74] S. Holgate,et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. , 1998, The Journal of clinical investigation.
[75] N. Thomson,et al. Drug-induced Asthma , 1998 .
[76] Tak H. Lee,et al. LEUKOTRIENES IN ASPIRIN-SENSITIVE ASTHMA , 1998 .
[77] M. Sanak,et al. Leukotriene C 4 synthase promoter polymorphism and risk of aspirin-induced asthma , 1997, The Lancet.
[78] L. Mastalerz,et al. Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin‐induced asthma , 1997, Allergy.
[79] J. Fujita,et al. Anti‐asthma effect of an antiviral drug, acyclovir: a clinical case and experimental study , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[80] J. Oates,et al. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. , 1996, American journal of respiratory and critical care medicine.
[81] S. Dahlén,et al. Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction. , 1996, The Journal of allergy and clinical immunology.
[82] R. M. Refini,et al. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. , 1996, American journal of respiratory and critical care medicine.
[83] L. Mastalerz,et al. Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma. , 1996, American journal of respiratory and critical care medicine.
[84] A. Szczeklik,et al. The atopy trait in hypersensitivity to nonsteroidal anti‐inflammatory drugs , 1996, Allergy.
[85] D. Stevenson,et al. Inhibition of monocyte leukotriene B4 production after aspirin desensitization. , 1995, The Journal of allergy and clinical immunology.
[86] T. Lee,et al. The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma. , 1995, American journal of respiratory and critical care medicine.
[87] I. Pavord,et al. Bronchoprotective role for endogenous prostaglandin E2 , 1995, The Lancet.
[88] S. Ghosh,et al. Inhibition of NF-kappa B by sodium salicylate and aspirin. , 1994, Science.
[89] P. Abrami,et al. Anaphylaxie et Idiosyncrasie , 1993 .
[90] A. Szczeklik,et al. The cyclooxygenase theory of aspirin-induced asthma. , 1990, The European respiratory journal.
[91] D. Stevenson,et al. Cross sensitivity with acetaminophen in aspirin-sensitive subjects with asthma. , 1989, The Journal of allergy and clinical immunology.
[92] A. Szczeklik,et al. Aspirin‐induced asthma as a viral disease , 1988, Clinical allergy.
[93] R. Simon,et al. Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period. , 1982, The Journal of allergy and clinical immunology.
[94] R. Simon,et al. Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. , 1980, The Journal of allergy and clinical immunology.
[95] E. Middleton,et al. Allergy, principles and practice , 1978 .
[96] A. Szczeklik,et al. Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. , 1977, The Journal of allergy and clinical immunology.
[97] A. Szczeklik,et al. Aspirin-sensitive asthma: the effect of aspirin on the release of prostaglandins from nasal polyps. , 1977, Pharmacological research communications.
[98] R. Lockey,et al. Refractory period to aspirin in a patient with aspirin-induced asthma. , 1976, The Journal of allergy and clinical immunology.
[99] A. Szczeklik,et al. PROSTAGLANDINS AND ASPIRIN-INDUCED ASTHMA , 1976, The Lancet.
[100] A. Szczeklik,et al. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. , 1975, British medical journal.
[101] M. Samter,et al. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. , 1968, Annals of internal medicine.